SUBSCRIBE
SUBSCRIBE

Novartis

NEWS
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Novartis AG’s Leukemia Drug Gets Breakthrough Designation, Same Week as AstraZeneca PLC and Roche Drugs
February 19, 2016
 · 
2 min read
Novartis to Hold On to Its 33% Stake in Roche—For Now
Business
Novartis AG Taps Former Hospira CEO to Rescue Alcon
January 27, 2016
 · 
3 min read
Business
GlaxoSmithKline CEO Might Consider Breakup After Novartis AG Deal Completion
January 13, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Tiny Surface Oncology Gets $170 Million Upfront in Next-Gen Cancer Deal with Novartis AG
January 11, 2016
 · 
3 min read
Job Trends
Novartis AG Finalizes Suffern, NY Plant Closure, Lays Off Remaining 61 Workers
December 30, 2015
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Job Trends
Novartis AG Opens New $600 Million Facility in Cambridge, Mass.
December 16, 2015
 · 
3 min read
Business
Novartis AG Pins Immuno-Oncology Hopes on 43-Year Old Harvard Research Star
December 16, 2015
 · 
3 min read
AbbVie Reveals Positive CLL Data at ASH
Drug Development
Novartis AG’s Experimental Therapy Wipes Out Blood Cancer in 93 Percent of Patients
December 8, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Novartis AG Fesses Up to Valeant-Like Pharmacy Scheme in $390 Million Settlement
November 23, 2015
 · 
3 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
FDA Says Unsure if Novartis AG MS Pill Caused Deaths
May 14, 2012
 · 
1 min read
Policy
FDA Voices Caution About Popular Bone Drugs, Including Novartis AG’s Reclast
May 11, 2012
 · 
1 min read
Policy
Novartis AG to Probe India Drug Approval Allegations
May 10, 2012
 · 
1 min read
Business
TV Host Phil Keoghan and Professional Women Cyclists Join Novartis Pharmaceuticals Corporation to Raise Awareness of Multiple Sclerosis
May 8, 2012
 · 
6 min read
Drug Development
Novartis AG: Pasireotide Works Well in Phase III Acromegaly Trial
May 8, 2012
 · 
16 min read
Novartis AG Plagued by Plant Problems in Austria, Too
May 4, 2012
 · 
1 min read
Business
Novartis AG Snags Fougera for $1.5 Billion for Generic Skin Drugs
May 3, 2012
 · 
1 min read
Drug Development
Novartis AG Drug for Smoker’s Cough Boosts Lung Function in Study
May 2, 2012
 · 
1 min read
Drug Development
Roche’s Avastin and Novartis AG’s Lucentis Equal for Treating Wet AMD - National Institutes of Health (NIH) Study
May 1, 2012
 · 
7 min read
FDA
FDA Approves Novartis AG’s Afinitor for Kidney Tumors
April 26, 2012
 · 
3 min read
Load More